Key Takeaways
- Shares closed down 11.37% at $688.80 Thursday, then rebounded 1.50% to $699.10 in extended trading.
- Company unveiled plans for a 240,000-square-foot Greensboro, NC manufacturing plant purchased from Qorvo, with production expected by mid-2028.
- NVIDIA disclosed as customer through existing strategic partnerships connected to the facility expansion.
- Recent quarterly results showed EPS of $1.67 versus $1.41 consensus, with revenue jumping 65.5% year-over-year to $665.5M.
- Price targets vary significantly — BNP Paribas projects $1,040 while analyst consensus averages $575.06; insiders offloaded approximately $38.9M in shares during the past 90 days.
Shares of Lumentum Holdings (LITE) experienced significant turbulence Thursday, plummeting 11.37% to settle at $688.80. Trading volume reached approximately 6.18 million shares — roughly 4% higher than typical daily activity.
However, the stock demonstrated resilience during extended trading hours. Shares climbed 1.50% to $699.10 after the company disclosed details about a significant domestic manufacturing expansion.
Lumentum revealed its purchase of a 240,000-square-foot production facility located in Greensboro, North Carolina, acquired from semiconductor manufacturer Qorvo. The location will focus on manufacturing indium phosphide-based optical components, encompassing continuous wave and ultra-high-power laser systems utilizing 6-inch InP wafers.
The facility aims to achieve full production capacity by mid-2028. CEO Michael Hurlston noted that customers are “constructing the infrastructure that will shape the future generation of computing.”
NVIDIA was identified as a client through existing strategic partnerships associated with the manufacturing expansion. NVIDIA’s EVP of Operations, Debora Shoquist, stated the development “enhances supply chain reliability and enables us to address increasing infrastructure requirements with assurance.”
The after-hours recovery indicates investors interpreted the session’s selloff as an attractive entry point rather than evidence of deteriorating fundamentals.
Impressive Financial Performance, Upgraded Outlook
Lumentum’s latest quarterly financial report provided substantial reasons for investor confidence. The company delivered earnings per share of $1.67, exceeding analyst projections of $1.41 by $0.26.
Total revenue reached $665.5 million — representing a 65.5% increase from the prior-year period and surpassing expectations of $646.74 million. Management issued Q3 2026 EPS guidance ranging from $2.15 to $2.35.
Nevertheless, shares have retreated from their 52-week peak of $808.80. The stock maintains an 84% premium over its 52-week bottom of $45.66, and has soared approximately 941.90% during the trailing twelve months.
Current pricing remains comfortably above both the 50-day moving average of $567.66 and the 200-day moving average of $363.11 — both significantly beneath today’s valuation.
Divergent Analyst Perspectives
Wall Street opinions vary considerably. BNP Paribas maintains a $1,040 price objective, suggesting roughly 47% potential appreciation from present levels.
Morgan Stanley kept an Equal-Weight stance while lifting its target from $520 to $595. Mizuho carries an “outperform” recommendation with a $645 projection.
The average rating from 19 analysts registers as “Moderate Buy” with a mean price target of $575.06 — presently trailing where shares currently trade.
Regarding insider activity, company executives divested approximately 65,775 shares valued at roughly $38.9 million during the previous 90-day period. Institutional investors control around 94% of outstanding shares.
LITE’s RSI registered 52.34 entering Friday’s session, while the company’s market capitalization stands at approximately $49.18 billion.
